Comparably Awards

Translating the biology of regulatory T cells (Tregs) into transformational medicines for patients with progressive multiple sclerosis and other serious autoimmune and inflammatory diseases. read more

EMPLOYEE PARTICIPANTS: 50

TOTAL RATINGS: 876

CEO: Samantha Singer

HR or Marketing? Claim Your Free Employer Account

Samantha Singer Abata Therapeutics CEO Rating

Abata Therapeutics' CEO, Samantha Singer, has 49 employee ratings and a score of 98/100, placing them in the Top 5% of similar size companies on Comparably with 11-50 Employees and Top 5% of other companies in Boston. When breaking the CEO score down by factors such as department, gender, and ethnicity, we see that males at Abata Therapeutics rate Samantha Singer higher than females, giving the CEO a score of 99/100.

Last updated months ago.

Where This Score Ranks Abata Therapeutics' CEO Rating

TOP
5%
In the Top 5% of 2054 Similar Sized Companies on Comparably
TOP
5%
In the Top 5% of 270 Nearby Companies in Boston
?
Not enough ratings to compare against competitors.

Aug

Sep

Oct

Feb

Jan

A+98 / 100

Jan

Abata Therapeutics CEO Samantha Singer Bio

Samantha Singer is an accomplished biotechnology leader and brings to Abata more than two decades of expertise in company creation, corporate development and operations.

Previously, she was an entrepreneur-in-residence at Third Rock Ventures, where she focused on company creation across the firm’s portfolio, including interim chief operating officer roles for Thrive Earlier Detection and Celsius Therapeutics. Prior to joining Third Rock, Samantha was the chief operating officer of the Broad Institute, where she oversaw the institute’s finance, business development, alliance management, facilities, information technology, human resources and legal teams. Previously, she served as vice president for corporate strategy and chief of staff for the CEO at Biogen. At Biogen, she also held leadership roles in organization effectiveness and global supply chain. Before Biogen, Samantha was a strategy consultant at the Boston Consulting Group and as an independent consultant focused on biotech companies and biomedical academic centers.

Samantha is a member of the board of directors of the 5:01 Special Acquisition Corp and the Institute for Protein Innovation. She previously served on the board of Rodin Therapeutics (acquired by Alkermes).

Samantha holds an M.S. in molecular biology from The Rockefeller University and an MBA from Harvard Business School.

Who Ranks Abata Therapeutics' CEO Rating the Highest?

Experience - Over 10 Years 99/100

Gender - Male 99/100

Department - Executive 98/100

Who Ranks Abata Therapeutics' CEO Rating the Lowest?

Ethnicity - Other 97/100

Ethnicity - Caucasian 98/100

Abata Therapeutics CEO Samantha Singer At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Abata Therapeutics.

Abata Therapeutics' CEO is highly regarded by employees with Over 10 Years experience, Male employees, and the Executive department. However, Caucasian employees have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.